Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)

Market Cap	8.40B -17.5%
Revenue (ttm)	3.11B +10.7%
Net Income	256.39M -10.7%
EPS	1.11 -12.7%
Shares Out	230.00M
PE Ratio	32.78
Forward PE	24.37
Dividend	0.33 (0.90%)
Ex-Dividend Date	Jul 1, 2026

Volume	85,889
Open	36.54
Previous Close	36.56
Day's Range	36.50 - 36.94
52-Week Range	27.20 - 43.30
Beta	-0.15
Analysts	Hold
Price Target	42.02 (+15.0%)
Earnings Date	Aug 11, 2026

About TADAWUL:4017

Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. The company operates through Medical Services; Education; and Trading, Retail & Others segments. It provides various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermat...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1978
• Employees: 2,672
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4017

Financial Performance

In 2025, TADAWUL:4017's revenue was 3.09 billion, an increase of 10.73% compared to the previous year's 2.79 billion. Earnings were 290.18 million, an increase of 0.91%.

Analyst Summary

According to 6 analysts, the average rating for 4017 stock is "Hold." The 12-month stock price target is SAR 42.02, which is an increase of 15.00% from the latest price.

Price Target

SAR 42.02

(15.00% upside)

Analyst Consensus: Hold